Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

OPKO Health Q2 Adj. EPS $(0.07) Beats $(0.11) Estimate, Sales $156.800M Miss $165.744M Estimate

Author: Benzinga Newsdesk | July 31, 2025 04:11pm
OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by 35.78 percent. This is a 600 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $156.800 million which missed the analyst consensus estimate of $165.744 million by 5.40 percent. This is a 13.94 percent decrease over sales of $182.200 million the same period last year.

Posted In: OPK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist